Insulet Appoints Independent Director Jonathan Mazelsky.
Insulet announced Jonathan J. Mazelsky will join its Board as an independent director effective July 1, 2026. Mazelsky’s extensive background in healthcare innovation is expected to bolster the company's strategy for expanding Omnipod access and driving shareholder value.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day